MY207501A - Ultraviolet light blocking composition comprising bis-ethylhexyloxyphenol methoxyphenyl triazine composite formulation - Google Patents

Ultraviolet light blocking composition comprising bis-ethylhexyloxyphenol methoxyphenyl triazine composite formulation

Info

Publication number
MY207501A
MY207501A MYPI2021005422A MYPI2021005422A MY207501A MY 207501 A MY207501 A MY 207501A MY PI2021005422 A MYPI2021005422 A MY PI2021005422A MY PI2021005422 A MYPI2021005422 A MY PI2021005422A MY 207501 A MY207501 A MY 207501A
Authority
MY
Malaysia
Prior art keywords
bis
methoxyphenyl triazine
ethylhexyloxyphenol methoxyphenyl
ultraviolet light
light blocking
Prior art date
Application number
MYPI2021005422A
Inventor
Byungfhy Suh
Hyung Jun Lim
Minah Kim
Sungil Park
Jeongeun Park
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020200055952A external-priority patent/KR102869153B1/en
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Publication of MY207501A publication Critical patent/MY207501A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

Disclosed herein is a water-in-oil type ultraviolet light-blocking composition that comprises: microparticles containing a polymer matrix in which bis-ethylhexyloxyphenol methoxyphenyl triazine is dispersed; and bis-ethylhexyloxyphenol methoxyphenyl triazine dissolved in a polar oil, in combination in the oil phase part. Compared to a composition that comprises microparticles containing a polymer matrix in which bis-ethylhexyloxyphenol methoxyphenyl triazine is dispersed, or bis-ethylhexyloxyphenol methoxyphenyl triazine dissolved in a polar oil alone, the present invention exhibits a further improved ultraviolet light blocking effect while containing a smaller amount of bis-ethylhexyloxyphenol methoxyphenyl triazine, and can provide a fresh sensation of use without stickiness. The most illustrative drawings : Figure 1a
MYPI2021005422A 2019-05-15 2020-05-13 Ultraviolet light blocking composition comprising bis-ethylhexyloxyphenol methoxyphenyl triazine composite formulation MY207501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20190057115 2019-05-15
KR1020200055952A KR102869153B1 (en) 2019-05-15 2020-05-11 Sun screen composition comprising a complex formulation of bis-ethylhexyloxyphenol methoxyphenyl triazine
PCT/KR2020/006261 WO2020231163A1 (en) 2019-05-15 2020-05-13 Ultraviolet light blocking composition comprising bis-ethylhexyloxyphenol methoxyphenyl triazine composite formulation

Publications (1)

Publication Number Publication Date
MY207501A true MY207501A (en) 2025-02-28

Family

ID=73289088

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2021005422A MY207501A (en) 2019-05-15 2020-05-13 Ultraviolet light blocking composition comprising bis-ethylhexyloxyphenol methoxyphenyl triazine composite formulation

Country Status (3)

Country Link
MY (1) MY207501A (en)
SG (1) SG11202110333TA (en)
WO (1) WO2020231163A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116898753B (en) * 2023-07-06 2026-02-17 广东工业大学 Composite particle with ultraviolet ray synergistic absorption performance and preparation method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2902648B1 (en) * 2006-06-22 2018-05-18 L'oreal AQUEOUS PHOTOPROTECTIVE COMPOSITION CONTAINING PAINTED OR ANNULAR PARTICLES OF SILICONE MATERIAL AND AT LEAST ONE UV FILTER
KR20090075299A (en) * 2008-01-04 2009-07-08 한불화장품주식회사 A sunscreen cosmetic composition containing a solid lipid capsule encapsulated with bisethylhexyloxyphenol methoxyphenyltriazine
KR101327826B1 (en) * 2011-11-22 2013-11-11 주식회사 제닉 Transparent Ultra-Violet Rays Screening Composition Of Water-in-oil Emulsion Type
KR102249023B1 (en) * 2014-01-28 2021-05-07 코스맥스 주식회사 Transparency spray type Sun Screening Cosmetic composition by Inorganic UV Filter
KR101833612B1 (en) * 2016-03-30 2018-02-28 선진뷰티사이언스(주) Polymer composite particles containing much of organic sunscreen agents and the method for preparing thereof
KR20180063664A (en) * 2016-12-02 2018-06-12 코오롱생명과학 주식회사 Hemi-sphere polymer bead containing uv absorbers and the method for preparing thereof

Also Published As

Publication number Publication date
SG11202110333TA (en) 2021-12-30
WO2020231163A1 (en) 2020-11-19

Similar Documents

Publication Publication Date Title
CL2021000650A1 (en) Modulators of pnpla3 expression
BR112015020050A2 (en) optical material, composite for optical material and its use
UY38403A (en) ALPHA-1 ANTITRYPSIN MODULATORS
CO2018003168A2 (en) Kras expression modulators
MX2010001903A (en) Gut flora and weight management.
BR112015023922A2 (en) pharmaceutical composition comprising an ampk activator and a serotonergic agent and methods of using these
CL2020001349A1 (en) Compounds, composition and use of the same as modulators of the expression of pcsk9. (divisional request 201902574)
BR102016008214B8 (en) SUN FILTER COMPOSITION
BRPI0518173A (en) ophthalmic composition and uses
CO2020015377A2 (en) Modulators of apol1 expression
FI3270909T3 (en) Fixed dose combinations comprising etc1002 and one or more statins for treating or reducing cardiovascular risk
AR003171A1 (en) CONCENTRATED COMPOSITION FOR THE CLEANING OF HARD SURFACES OF THE WATER AROMATIZING TYPE AND OF GERMICIDAL ACTION, CONCENTRATE AND COMPOSITION OF PINE OIL AND PROCEDURE FOR TREATING SUCH SURFACES.
MY207501A (en) Ultraviolet light blocking composition comprising bis-ethylhexyloxyphenol methoxyphenyl triazine composite formulation
BR112021014566A2 (en) gpr35 modulators
UY39146A (en) ATTENUATING FEED COMPOSITIONS TO INACTIVATE SWINE VIRUSES AND RELATED PROCEDURES
DK1706133T3 (en) Methods of protection against radiation using flagellin
MX2015016931A (en) A marine oil formulation comprising reservatrol or derivatives thereof for use in treating, delaying and/or preventing alzheimer's desease.
BRPI0512183A (en) effective cosmetic or dermatological preparations for protection against
EP4342985A3 (en) Pharmaceutical composition for preventing or treating cancer comprising anticancer virus and hydroxyurea as effective components
BR112022010750A2 (en) METHOD TO TREAT CANCER USING ARTIFICIAL ADJUVANT CELL (AVC)
BRPI0418293A (en) composition comprising an aqueous extract of red grape vine leaves and a diuretic for the treatment of chronic venous insufficiencies
CL2021000107A1 (en) Methods of treating hfpef using dapagliflozin and compositions comprising the same
BR112012020385A2 (en) composition conferring UV protective ability, use of the composition, method of attenuating the effects of UV light on a substrate exposed to solar radiation, and substrate coated with or formed of a composition
BRPI0815599A2 (en) USE OF A FLUOROQUINOLONE, METHODS FOR MODULATING ENDHTHALMITE IN AN INDIVIDUAL AND TO TREAT OR CONTROLING AN Ophthalmic OR EYE INFECTION THAT RESULT IN ENDHTHALMITE IN AN INDIVIDUAL AND PHARMACEUTICAL COMPOSITION.
CL2022001015A1 (en) Use of imidazopyrimidine or imidazotriazine compounds for prevention, relief or treatment of cognitive disorders.